Seeking Alpha
Research analyst, IPOs, long/short equity
Profile| Send Message|
( followers)  

The following IPOs are expected to price this week:

Caesars Entertainment (NASDAQ:CZR), a casino entertainment provider owned by TPG and Apollo, plans to raise $16 million by offering 1,811,313 shares at a price range of $8.00 to $10.00. At the midpoint of the proposed range, Caesars Entertainment will command a market value of $1.14 billion. Caesars Entertainment, which was founded in 1989, booked $8.8 billion in sales over the last 12 months. The Las Vegas, NV-based company plans to list on the NASDAQ under the symbol CZR. Credit Suisse, Citi, and BofA Merrill Lynch are the lead underwriters on the deal.

Cementos Pacasmayo SAA (NYSE:CPAC), which produces and distributes cement for construction in Peru, plans to raise $245 million by offering 20,000,000 shares at a price range of $11.50 to $13.00. At the midpoint of the proposed range, Cementos Pacasmayo SAA will command a market value of $1.39 billion. Cementos Pacasmayo SAA, which was founded in 1949, booked $349 million in sales over the last 12 months. The Lima, Peru-based company plans to list on the NYSE under the symbol CPAC. J.P. Morgan is the lead underwriter on the deal. Please note: We are not issuing research on this IPO.

Ceres (NASDAQ:CERE), which sells seeds used to produce renewable bioenergy feedstocks, plans to raise $110 million by offering 5,000,000 shares at a price range of $21.00 to $23.00. At the midpoint of the proposed range, Ceres will command a market value of $550.30 million. Ceres, which was founded in 1996, booked $7 million in sales over the last 12 months. The Thousand Oaks, CA-based company plans to list on the NASDAQ under the symbol CERE. Goldman, Sachs & Co. and Barclays Capital are the lead underwriters on the deal.

ChemoCentryx (NASDAQ:CCXI), which is developing novel drugs for Crohn's disease and rheumatoid arthritis with Glaxo, plans to raise $60 million by offering 4,000,000 shares at a price range of $14.00 to $16.00. At the midpoint of the proposed range, ChemoCentryx will command a market value of $554.76 million. ChemoCentryx, which was founded in 1997, booked $19 million in sales over the last 12 months. The Mountain View, CA-based company plans to list on the NASDAQ under the symbol CCXI. J.P. Morgan and Citi are the lead underwriters on the deal.

EPAM Systems (NYSE:EPAM), an offshore IT services provider with delivery centers in Eastern Europe, plans to raise $126 million by offering 7,400,000 shares at a price range of $16.00 to $18.00. At the midpoint of the proposed range, EPAM Systems will command a market value of $777.86 million. EPAM Systems, which was founded in 1993, booked $310 million in sales over the last 12 months. The Newtown, PA-based company plans to list on the NYSE under the symbol EPAM. Citi, UBS Investment Bank, and Barclays Capital are the lead underwriters on the deal.

FX Alliance (NYSE:FX), which operates a leading independent, institutional foreign exchange trading platform, plans to raise $75 million by offering 5,200,000 shares at a price range of $13.50 to $15.50. At the mid-point of the proposed range, FX Alliance will command a market value of $425.56 million. FX Alliance, which was founded in 2000, booked $114 million in sales over the last 12 months. The New York, NY-based company plans to list on the NYSE under the symbol FX. BofA Merrill Lynch, Goldman, Sachs & Co., and Citi are the lead underwriters on the deal.

GSE Holding (NYSE:GSE), a global maker of containment products for mining, waste and water management, plans to raise $63 million by offering 7,000,000 shares at a price range of $8.00 to $10.00. At the midpoint of the proposed range, GSE Holding will command a market value of $175.97 million. GSE Holding was founded in 1981. The Houston, TX-based company plans to list on the NYSE under the symbol GSE. Oppenheimer & Co., William Blair, and FBR Capital Markets are the lead underwriters on the deal. Please note: Relaunched after postponing on 12/15/11. Prior terms 9 million shares at $13 to $15.

Roundy's (NYSE:RNDY), a midwest supermarket chain with 158 stores in Wisconsin, Minnesota and Illinois, plans to raise $200 million by offering 18,181,818 shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Roundy's will command a market value of $456.30 million. Roundy's, which was founded in 1872, booked $3.8 billion in sales over the last 12 months. The Milwaukee, WI-based company plans to list on the NYSE under the symbol RNDY. Credit Suisse, J.P. Morgan, and Jefferies & Co. are the lead underwriters on the deal.

Synacor (NASDAQ:SYNC), which enables cable/telecom service providers to offer consumers online content/services, plans to raise $75 million by offering 6,818,170 shares at a price range of $10.00 to $12.00. At the mid-point of the proposed range, Synacor will command a market value of $326.45 million. Synacor, which was founded in 1998, booked $80 million in sales over the last 12 months. The Buffalo, NY-based company plans to list on the NASDAQ under the symbol SYNC. BofA Merrill Lynch and Citi are the lead underwriters on the deal.

TVAX Biomedical (TVAX), a biotech company focused on cancer cell vaccination and T cell cancer treatment, plans to raise $20 million by offering 2,000,000 shares at a price range of $9.00 to $11.00. At the midpoint of the proposed range, TVAX Biomedical will command a market value of $80.93 million. TVAX Biomedical, which was founded in 2004, has not yet booked any operating revenues. The Lenexa, KS-based company plans to list on the NASDAQ under the symbol TVAX. Roth Capital is the lead underwriter on the deal. Please note: We are not issuing research on this IPO.

Last week, there were 5 IPO pricings. Greenway Medical Technologies (NYSE:GWAY), which provides integrated IT solutions and services to US physicians, was the week's winner, ending up 33% from its IPO price.

Source: 10 U.S. IPOs Planned For The Week Of Feb. 6